PLX icon

Protalix BioTherapeutics

47 hedge funds and large institutions have $159M invested in Protalix BioTherapeutics in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding

Funds holding: 4747 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

95% less call options, than puts

Call options by funds: $210K | Put options by funds: $3.84M

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$210K
Puts
$3.84M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$47.2M
2
$34.7M
3
$25.1M
4
$9.78M
5
$8.11M
6
$5.34M
7
$5.2M
8
$4.72M
9
$2.27M
10
$2.04M
11
$1.98M
12
$1.81M
13
$1.23M
14
$1.16M
15
$1.09M
16
$1.09M
17
$906K
18
$829K
19
$544K
20
$412K
21
$344K
22
$323K
23
$287K
24
$274K
25
$270K